Bristol-Myers Squibb Co on Friday said it won a US$752 million jury verdict against Gilead Sciences Inc in a U.S. patent dispute relating to technology for treating cancer.
Bristol-Myers wins US$752 million in US patent case against Gilead
- Advertisement -
